Announcement

Collapse
No announcement yet.

FDA rejects Oral Cladribine for MS

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • FDA rejects Oral Cladribine for MS

    Concerns about safety, in particular a potential rise of cancer, has this new oral drug still sitting on the shelf. After too-fast approvals that have led to serious consequences, I can see why the FDA is being so cautious and requiring more study....

    http://www.medscape.com/viewarticle/738239
    Dave Bexfield
    ActiveMSers
Working...
X